Predictmedix AI Inc.
PMEDF
$0.0319
$0.009542.41%
PMEDF
Valuation
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Market Cap
4.61M
< 2.87M
> 11.50M
Enterprise Value
5.16M
1.04M
15.22M
Price/Earnings (TTM)
-5.70
-9.12
-0.47
Earnings Per Share Growth (TTM)
-60.56%
-60.56%
> 0.00%
Price/Earnings To Growth (TTM)
--
--
--
Price/Sales (TTM)
--
9.44
475.00
Price/Book (Q)
-7.25
< -10.00
> 140.00
Enterprise Value/Revenue (TTM)
--
32.47
2,540.21
Enterprise Value/EBITDA (TTM)
-6.60
< -10.00
-0.72
Enterprise Value/EBIT (TTM)
-6.41
< -10.00
-0.71
Dividends and Shares
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Shares Outstanding
150.26M
122.01M
150.34M
Dividend Per Share (Most Recent)
--
--
--
Dividend Per Share (TTM)
--
--
--
Dividend Yield (TTM)
--
--
--
Payout Ratio (TTM)
--
--
--
Price History
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Beta
-1.64
-3.39
1.70
1-Month Total Return
1.59%
< 0.00%
> 10.00%
3-Month Total Return
336.39%
< 0.00%
> 340.00%
6-Month Total Return
473.74%
< 0.00%
473.74%
Year to Date Total Return
199.25%
< 10.00%
> 200.00%
1-Year Total Return
-16.49%
< -60.00%
> -10.00%
2-Year Total Return
-72.02%
-94.42%
> -30.00%
3-Year Total Return
-65.10%
-98.39%
> -40.00%
5-Year Total Return
-63.75%
-87.11%
-63.75%
Profitability
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Operating Margin (TTM)
--
-52,285.71%
-5,416.54%
Profit Margin (TTM)
--
-53,974.28%
-5,758.82%
Management Effectiveness
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Return on Assets (TTM)
-149.72%
-205.65%
-121.98%
Return on Equity (TTM)
--
--
--
Income Statement
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Revenue (TTM)
--
3.50K
27.20K
Total Revenue (TTM)
--
3.50K
27.20K
Total Revenue Growth (Q YOY)
--
--
--
Revenue Per Share (TTM)
--
0.00
0.00
Gross Profit (TTM)
--
3.50K
13.90K
EBITDA (TTM)
-783.00K
-1.76M
-783.00K
EBIT (TTM)
-806.10K
-1.84M
-806.10K
Net Income (TTM)
-840.70K
-1.90M
-840.70K
Net Income Avl. to Common (TTM)
-840.70K
-1.90M
-840.70K
Earnings Growth (Q YOY)
47.39%
< 20.00%
63.72%
EPS Diluted (TTM)
-0.01
-0.01
-0.01
EPS Diluted Growth (Q YOY)
45.45%
26.67%
67.86%
Balance Sheet
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Cash and Short-Term Inv. (Q)
--
4.90K
162.50K
Cash Per Share (Q)
--
0.00
0.00
Total Current Assets (Q)
44.80K
37.30K
305.90K
Total Assets (Q)
257.20K
257.20K
683.30K
Total Current Liabilities (Q)
912.90K
261.70K
912.90K
Total Debt (Q)
0.00
0.00
31.80K
Total Liabilities (Q)
912.90K
261.70K
912.90K
Total Common Equity (Q)
-655.70K
-655.70K
> 0.00
Total Preferred Equity (Q)
--
--
--
Total Equity (Q)
-655.70K
-655.70K
> 0.00
Current Ratio (Q)
0.049
0.048
1.169
Book Value Per Share (Q)
0.00
0.00
> 0.00
Cash Flow
PMEDF
Low
2-Year Historical Range
PMEDF
Average
High
Cash from Operations (TTM)
-32.70K
-1.41M
-32.70K
Cash from Investing (TTM)
--
-111.10K
-44.40K
Cash from Financing (TTM)
0.00
0.00
1.40M
Net Change in Cash (TTM)
-32.70K
-152.40K
> 0.00
Levered Free Cash Flow (TTM)
304.50K
-873.20K
304.50K
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
